The Ophthalmic Lasers Market size is expected to grow at an annual average of 5% during 2021-2027. The photocoagulation market is expected to generate the largest revenue in the global ophthalmic laser market. This is because it has been used in the treatment of macular edema, proliferative retinopathy, etc., which are increasingly widespread geographically.
(Get 15% Discount on Buying this Report)
A full report of Ophthalmic Lasers Market is available at: https://www.orionmarketreports.com/ophthalmic-lasers-market/54966/
The following segmentation are covered in this report:
By Product Type
- Femtosecond Lasers
- Excimer Lasers
- Nd:YAG Lasers
- Diode Lasers
- Other Lasers [Nd:YAG Lasers operating in green (532 NM) wavelength, solid-state lasers, optically pumped semiconductor lasers, and lasers with fiber technology]
By Application
- Refractive Error Correction
- Cataract Removal
- Glaucoma Treatment
- Diabetic Retinopathy Treatment
- AMD Treatment
Company Profile
- Alcon Laboratories Inc. (Novartis AG)
- Johnson & Johnson Surgical Vision Inc.
- Bausch & Lomb Incorporated (Valeant Pharmaceuticals International Inc.)
- Ellex Medical Lasers Limited
- IRIDEX Corporation
- LIGHTMED
- Quantel Medical
- SCHWIND eye-tech-solutions
- Lumenis
The report covers the following objectives:
- Proliferation and maturation of trade in the global Ophthalmic Lasers Market
- The market share of the global Ophthalmic Lasers Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Ophthalmic Lasers Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Ophthalmic Lasers Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
